| Literature DB >> 34824868 |
Fan Li1, Yiming Huo2, Lihua Ma1, Qing Zhang1, Hengli Zhang1, Xiaowei Yan1, Yulei Geng1, Guangxian Tang1.
Abstract
PURPOSE: To evaluate the differences in macular choroidal thickness and volume among patients with pseudoexfoliative glaucoma (PXG), patients with primary open-angle glaucoma (POAG), and controls.Entities:
Year: 2021 PMID: 34824868 PMCID: PMC8610724 DOI: 10.1155/2021/3897952
Source DB: PubMed Journal: J Ophthalmol ISSN: 2090-004X Impact factor: 1.909
Baseline characteristics of the study groups are shown in three groups.
| Groups | Eyes ( | Gender ( | Age (years) | AL (mm) | MD (dB) | Time (days) | Pretreatment IOP (mmHg) | Posttreatment IOP (mmHg) | Antiglaucoma medications ( |
|---|---|---|---|---|---|---|---|---|---|
| M/F | |||||||||
| PXG | 50 | 25/25 | 75.36 ± 6.75 | 23.19 ± 0.99 | −16.76 ± 9.53 | 58.70 ± 50.56 | 30.36 ± 7.82 | 16.30 ± 2.97 | 2.78 ± 1.02 |
| POAG | 56 | 22/34 | 73.66 ± 6.23 | 23.26 ± 0.88 | −14.66 ± 8.98 | 65.75 ± 49.92 | 27.43 ± 8.11 | 16.16 ± 2.37 | 2.69 ± 1.01 |
| Control | 54 | 20/34 | 73.70 ± 4.85 | 23.22 ± 0.89 | −1.04 ± 0.41 | — | — | 15.46 ± 2.52 | — |
|
| 2.030 | 1.355 | 0.084 | 68.338 | 0.01 | 0.448 | 1.702 | 197.657 | |
|
| 0.362 | 0.261 | 0.919 | <0.001 | 0.473 | 0.062 | 0.186 | <0.001 |
PXG: pseudoexfoliative glaucoma; POAG: primary open-angle glaucoma; M: male; F: female; IOP: intraocular pressure; AL: axial length; MD: mean defect; Time: duration between the first diagnosis and study enrolment.
Figure 1Measurement illustration of macular choroidal thickness at nine locations (reproduced from Li et al. [12]). CSM: central subfield macula; NIM: nasal inner macula; SIM: superior inner macula; IIM: inferior inner macula; TIM: temporal inner macula; NOM: nasal outer macula; SOM: superior outer macula; IOM: inferior outer macula; TOM: temporal outer macula.
Figure 2Optical coherence tomographic image (enhanced-depth imaging mode) for the measurement of the macular choroidal thickness.
Comparisons of macular choroidal thickness by EDI-OCT in three groups.
| Regions | PXG (50 eyes) | POAG (56 eyes) | Control (54 eyes) | |||
|---|---|---|---|---|---|---|
| TH ( |
| TH ( |
| TH ( |
| |
| CSM | 181.46 ± 56.46a | 0.14 ± 0.05 | 205.45 ± 74.41b | 0.16 ± 0.06 | 212.13 ± 55.34 | 0.17 ± 0.04 |
| NIM | 164.76 ± 54.85 | 0.26 ± 0.09 | 189.25 ± 75.97 | 0.30 ± 0.12 | 186.81 ± 54.61 | 0.29 ± 0.09 |
| SIM | 192.10 ± 59.54 | 0.30 ± 0.09 | 207.59 ± 68.53 | 0.33 ± 0.11 | 216.35 ± 51.66 | 0.34 ± 0.08 |
| TIM | 182.62 ± 55.60a | 0.29 ± 0.09a | 202.18 ± 68.75 | 0.32 ± 0.11 | 216.28 ± 51.73 | 0.34 ± 0.08 |
| IIM | 169.64 ± 58.91a | 0.27 ± 0.09a | 203.07 ± 81.16b | 0.32 ± 0.13b | 195.56 ± 55.16 | 0.31 ± 0.08 |
| NOM | 132.48 ± 45.11 | 0.70 ± 0.24 | 155.55 ± 71.30 | 0.83 ± 0.38 | 153.81 ± 55.48 | 0.82 ± 0.29 |
| SOM | 191.32 ± 54.86 | 1.01 ± 0.29 | 201.89 ± 67.57 | 1.07 ± 0.36 | 211.93 ± 45.34 | 1.12 ± 0.24 |
| TOM | 168.72 ± 46.02a | 0.88 ± 0.25a | 187.14 ± 57.78 | 0.99 ± 0.31b | 201.30 ± 46.34 | 1.06 ± 0.24 |
| IOM | 163.10 ± 54.82 | 0.86 ± 0.29 | 189.89 ± 75.44 | 1.00 ± 0.41 | 185.52 ± 50.27 | 0.98 ± 0.27 |
| MM | 171.80 ± 50.46a | 0.52 ± 0.15a | 193.56 ± 68.26b | 0.59 ± 0.21b | 197.74 ± 46.82 | 0.60 ± 0.14 |
PXG: pseudoexfoliative glaucoma; POAG: primary open-angle glaucoma; comparison between the PXG group and control group by LSD t-test, aP < 0.05; comparison between the PXG group and POAG group by LSD t-test, bP < 0.05; CSM: central subfield macula; NIM: nasal inner macula; SIM: superior inner macula; IIM: inferior inner macula; TIM: temporal inner macula; NOM: nasal outer macula; SOM: superior outer macula; IOM: inferior outer macula; TOM: temporal outer macula; MM: mean macula; TH: thickness; V: volume. Data are expressed as mean ± standard deviation.